Main Menu
VanNess & VanNess, P.A.
Toll Free: 866-697-6221 Local: 352-436-4333 Over 100 years of combined experience

New class of cancer drug, Keytruda offers hope for lung cancer and mesothelioma patients

Earlier this month the FDA approved Keytruda, manufactured by Merck, to treat melanoma. Keytruda disrupts the cancer cells that tell the body's immune system not to attack the cancer cells as intruders. Keytruda, and other drugs in this class are already being tested on other types of cancers including small cell lung cancer and mesothelioma caused by exposure to dangerous asbestos fibers.

VanNess & VanNess, P.A.